Hongmei Zheng
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
PLIN3 knockdown enhances T cell-mediated cytotoxicity in non-small cell lung cancer via autophagy-dependent PD-L1 degradation.
Journal: International immunopharmacology
Published: February 11, 2026
The Role of Hedgehog Signaling in Non-small Cell Lung Cancer: Targeting Tumor Invasion, Therapy Resistance and Novel Therapeutic Strategies.
Journal: International journal of biological sciences
Published: August 07, 2025
A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features.
Journal: Cancer biology & therapy
Published: January 30, 2025
YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway.
Journal: Cancer cell international
Published: January 09, 2025
A comprehensive analysis identified an autophagy-related risk model for predicting recurrence and immunotherapy response in stage I lung adenocarcinoma.
Journal: PeerJ
Published: November 19, 2024
Itraconazole Reversing Acquired Resistance to Osimertinib in NSCLC by Inhibiting the SHH/DUSP13B/p-STAT3 Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 13, 2024
MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancer.
Journal: Scientific reports
Published: June 22, 2024
Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.
Journal: Critical reviews in oncology/hematology
Published: September 03, 2023
New insights into the important roles of phase seperation in the targeted therapy of lung cancer.
Journal: Cell & bioscience
Published: May 29, 2023
G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway.
Journal: International journal of biological sciences
Published: April 16, 2023
YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer.
Journal: International journal of biological sciences
Published: October 17, 2022
Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer.
Journal: Journal of Cancer
Published: July 31, 2022
Last Updated: 09/26/2026